KAVISH PATIDAR to Liver Cirrhosis
This is a "connection" page, showing publications KAVISH PATIDAR has written about Liver Cirrhosis.
Connection Strength
6.683
-
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort study. Lancet Gastroenterol Hepatol. 2025 May; 10(5):418-430.
Score: 0.588
-
Hospital-Acquired Versus Community-Acquired Acute Kidney Injury in Patients With Cirrhosis: A Prospective Study. Am J Gastroenterol. 2020 09; 115(9):1505-1512.
Score: 0.430
-
Associations Between Mean Arterial Pressure and Poor ICU Outcomes in Critically Ill Patients With Cirrhosis: Is 65 The Sweet Spot? Crit Care Med. 2020 09; 48(9):e753-e760.
Score: 0.430
-
Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. J Hepatol. 2020 11; 73(5):1092-1099.
Score: 0.421
-
Development and Validation of a Model to Predict Acute Kidney Injury in Hospitalized Patients With Cirrhosis. Clin Transl Gastroenterol. 2019 09; 10(9):e00075.
Score: 0.402
-
Admission plasma uromodulin and the risk of acute kidney injury in hospitalized patients with cirrhosis: a pilot study. Am J Physiol Gastrointest Liver Physiol. 2019 10 01; 317(4):G447-G452.
Score: 0.400
-
Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis. Hepatology. 2018 07; 68(1):224-233.
Score: 0.367
-
No Association Between Quick Sequential Organ Failure Assessment and Outcomes of Patients With Cirrhosis and Infections. Clin Gastroenterol Hepatol. 2017 11; 15(11):1803-1804.
Score: 0.343
-
Symptom Domain Groups of the Patient-Reported Outcomes Measurement Information System Tools Independently Predict Hospitalizations and Re-hospitalizations in Cirrhosis. Dig Dis Sci. 2017 05; 62(5):1173-1179.
Score: 0.338
-
Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol. 2014 Nov; 109(11):1757-63.
Score: 0.284
-
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium. Liver Transpl. 2024 Nov 01; 30(11):1106-1115.
Score: 0.141
-
Cystatin C and the difference between cystatin C and serum creatinine: Improved metrics to predict waitlist mortality among patients with decompensated cirrhosis. Liver Transpl. 2025 Jan 01; 31(1):24-31.
Score: 0.141
-
Medication burden and anticholinergic use are associated with overt HE in individuals with cirrhosis. Hepatol Commun. 2024 08 01; 8(8).
Score: 0.141
-
Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Nov 01; 119(11):2259-2266.
Score: 0.140
-
Performance of race-neutral eGFR equations in patients with decompensated cirrhosis. Liver Transpl. 2025 Feb 01; 31(2):170-180.
Score: 0.140
-
Controversies in terlipressin and transplantation in the United States: How do we MELD the two? Liver Transpl. 2024 Jul 01; 30(7):753-759.
Score: 0.138
-
The association between mean arterial pressure and acute kidney injury reversal among patients with decompensated cirrhosis. Hepatology. 2025 Jan 01; 81(1):126-135.
Score: 0.138
-
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study. Liver Transpl. 2024 03 01; 30(3):244-253.
Score: 0.132
-
Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023 06; 57(12):1397-1406.
Score: 0.128
-
Recent Advances in the Management of Hepatorenal Syndrome: A US Perspective. Clin Gastroenterol Hepatol. 2023 04; 21(4):897-901.e1.
Score: 0.128
-
The prognostic impact of acute kidney injury recovery patterns in critically ill patients with cirrhosis. Liver Transpl. 2023 03 01; 29(3):246-258.
Score: 0.128
-
Acute kidney disease is common and associated with poor outcomes in patients with cirrhosis and acute kidney injury. J Hepatol. 2022 07; 77(1):108-115.
Score: 0.119
-
Practice patterns and outcomes associated with intravenous albumin in patients with cirrhosis and acute kidney injury. Liver Int. 2022 01; 42(1):187-198.
Score: 0.117
-
Bleeding After Elective Interventional Endoscopic Procedures in a Large Cohort of Patients With Cirrhosis. Clin Transl Gastroenterol. 2020 12 17; 11(12):e00288.
Score: 0.110
-
Improving Outcomes of Bariatric Surgery in Patients With Cirrhosis in the United States: A Nationwide Assessment. Am J Gastroenterol. 2020 11; 115(11):1849-1856.
Score: 0.109
-
Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy. Dig Dis Sci. 2021 08; 66(8):2603-2609.
Score: 0.108
-
Features of Blood Clotting on Thromboelastography in Hospitalized Patients With Cirrhosis. Am J Med. 2020 12; 133(12):1479-1487.e2.
Score: 0.106
-
Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2016 Apr; 36(4):572-9.
Score: 0.078
-
Outcomes of patients with alcohol-associated hepatitis and acute kidney injury - Results from the HRS Harmony Consortium. Aliment Pharmacol Ther. 2024 Sep; 60(6):778-786.
Score: 0.035
-
From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury. Hepatology. 2025 Jun 01; 81(6):1878-1897.
Score: 0.034
-
Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis. Am J Gastroenterol. 2024 02 01; 119(2):287-296.
Score: 0.033
-
Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol. 2023 12; 79(6):1408-1417.
Score: 0.033
-
Trends in Racial and Ethnic Disparities in the Receipt of Lifesaving Procedures for Hospitalized Patients With Decompensated Cirrhosis in the US, 2009-2018. JAMA Netw Open. 2023 07 03; 6(7):e2324539.
Score: 0.033
-
PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023 12 01; 78(6):1788-1799.
Score: 0.033
-
Cirrhotic cardiomyopathy: Predictors of major adverse cardiac events and assessment of reversibility after liver transplant. J Cardiol. 2023 08; 82(2):113-121.
Score: 0.032
-
Confusion assessment method accurately screens for hepatic encephalopathy and predicts short-term mortality in hospitalized patients with cirrhosis. Metab Brain Dis. 2023 06; 38(5):1749-1758.
Score: 0.032
-
Measuring Medication Use, Obstacles, and Knowledge in Individuals With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1819-1830.e5.
Score: 0.031
-
Palliative Care, Patient-Reported Measures, and Outcomes in Hospitalized Patients With Cirrhosis. J Pain Symptom Manage. 2022 06; 63(6):953-961.
Score: 0.030
-
Eight-Fold Increase in Dietary Supplement-Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States. Liver Transpl. 2022 02; 28(2):169-179.
Score: 0.029
-
Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1426-e1437.
Score: 0.029
-
Insight into an acute hepatitis A outbreak in Indiana. J Viral Hepat. 2021 06; 28(6):964-971.
Score: 0.028
-
Extra-hepatic comorbidity burden significantly increases 90-day mortality in patients with cirrhosis and high model for endstage liver disease. BMC Gastroenterol. 2020 Sep 16; 20(1):302.
Score: 0.027